2019 AFib Guidelines Made Simple Tool

2019 AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients with Atrial FibrillationGUIDELINES MADE Simple - Focused Update EditionA selection of Tables and Figures 2018, American College of Cardiology AHA/ACC/HRS Focused Update of the 2014 Guideline for Management of Patients with Atrial FibrillationA report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines , and the Heart Rhythm SocietyCraig T. January, MD, PhD, FACC, ChairL. Samuel Wann, MD, MACC, FAHA, Vice Chair Hugh Calkins, MD, FACC, FAHA, FHRSLin Y. Chen, MD, MS, FACC, FAHA, FHRSJ oaquin E. Cigarroa, MD, FACCJ oseph C. Cleveland, Jr, MD, FACCP atrick T. Ellinor, MD, PhDMichael Exekowitz, MBChB, DPhil, FACC, FAHAM ichael E. field, MD, FACC, FAHA, FHRSK aren Furie, MD, MPH, FAHAPaul Heidenreich, MD, FACC, FAHAK atherine T. Murray, MD, FACC, FAHA, FHRSJ ulie B. Shea, MS, RNCS, FHRSC ynthia M. Tracy, MDClyde W. Yancy, MD, MACC, FAHACITATION: Committee:The purpose of the 2019 Focused Update is to update the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation in areas where new evidence has emerged since its publication.

Section 4.1.1 - Selection of Antithrombotic Regimen Section 6.1.1 - Prevention of Thromboembolism I IIa IIb III Oral anticoagulants recommended for high risk patients now include edoxaban. Exclusion criteria for CHA 2 DS 2-VASc assessment and use of NOACs now defined as moderate to severe mitral stenosis or a mechanical heart valve.

Loading..

Tags:

  Guidelines, Selection

Information

Related search queries